表紙
市場調査レポート

世界の血漿市場:動向、機会、2015〜2020年の予測-血漿IVIG、アルブミン、第VIII因子、地域別 (北米、欧州、アジア太平洋地域) 、市場参入戦略

Global Blood Plasma Market: Trends, Opportunities and Forecasts 2015-2020

発行 Azoth Analytics 商品コード 348328
出版日 ページ情報 英文
即納可能
価格
本日の銀行送金レート: 1USD=106.12円で換算しております。
Back to Top
世界の血漿市場:動向、機会、2015〜2020年の予測-血漿IVIG、アルブミン、第VIII因子、地域別 (北米、欧州、アジア太平洋地域) 、市場参入戦略 Global Blood Plasma Market: Trends, Opportunities and Forecasts 2015-2020
出版日: 2016年01月05日 ページ情報: 英文
概要

2015〜2020年にかけて、世界の血漿市場は急速に成長すると予測されています。高齢化や医療費の高騰、新製品の研究開発などで着実に需要が高まり、市場成長につながっています。

レポートでは、世界の世界の腫瘍焼灼市場について調査し、市場の規模と2019年までの成長率、市場の動向と課題、主要ベンダー、市場の機会と脅威、地域別市場シェアなどをまとめています。

第1章 調査方法

第2章 製品概要

第3章 エグゼクティブサマリー

第4章 世界の血漿市場:分析

  • 市場規模、成長、予測
  • セグメントシェアおよび分析
  • アルブミン
  • IVIG
  • 第VIII因子
  • その他

第5章 北米市場

第6章 アジア太平洋地域市場

第7章 欧州市場

第8章 その他の地域

第9章 市場動向

第10章 世界の血漿市場動向

  • 成長促進因子
  • 課題

第11章 政策と法規制環境

第12章 バリューチェーン分析

第13章 貿易データ分析

第14章 ファイブフォース分析

第15章 競合環境

第16章 企業プロファイル

第17章 主要ベンダー分析

  • CSL Ltd.
  • 16.2Baxter International Inc
  • 16.3Grifols S.A
  • 16.4Antares Pharma Inc
  • 16.5Emergent BioSolutions, Inc.
  • 16.6AMAG Pharmaceuticals, Inc.
  • 16.7Cipla
  • 16.8Octopharma
  • 16.9Biota Pharmaceuticals, Inc.
  • 16.10BioDelivery Sciences International, Inc.

第17章 戦略的提言

図表

目次

Executive Summary

The market is driven by the consumer awareness of health care resulting in access for treatment along with increase in the global ageing populace which faces these kind of health problems at that age.

Global Blood Plasma Market is a growing market with key players holding dominant positions and is classified on the basis of drugs market. Global Blood Plasma Market has been growing at an average pace over the last five years on account of growing number of old people and the demand in the different regions .

During 2015-20, Global Blood Plasma Market is anticipated to grow at an increased rate on account of the rapid increase of the healthcare expenditure on the diseases related to the blood plasma i.e. immunodeficiency, clotting disabilities etc..

The plasma market is still on the growing end at a CAGR of 10.54% where major players are having strong presence in market, considering more number of patients being treated for these diseases. The growth in ageing population, rise in healthcare expenditure and R&D of the new products also create a demand for the products making the market to grow at a steady pace.

According to Azoth Analytics research report, Global Blood Plasma Market: Trends, Opportunities and Forecasts (2015-2020) - (By Market Segment, Type of Blood Plasma -IVIG, Albumin, Factor VIII, By Region-North America, Europe, APAC, Market Entry Strategies for Global Players), global blood plasma market is projected to exhibit a CAGR of 10.54% during 2015 - 2020. Few of the leading companies operating in blood plasma market in world include CSL Behring, Baxter, Grifols SA and Octapharma, etc.

Scope of the Report

“Global Blood Plasma Market: Trends, Opportunities and Forecasts (2015-2020) - (By Market Segment, Type of Blood Plasma -IVIG, Albumin, Factor VIII, By Region-North America, Europe, APAC, Market Entry Strategies for Global Players)” analyses the following aspects of Global Blood Plasma Market:

  • Analysis of Key Market Segments - IVIG, Albumin, Factor VIII
  • Analysis of Key Market Segments - IVIG, Albumin, Factor VIII BY Geography - North America, Europe, APAC
  • Executive Summary - Market, Drivers & Challenges and Trends.
  • Global Blood Plasma Market, Size & Forecast.

Why You Should Buy This Report?

  • To gain an in-depth understanding of Global Blood Plasma Market
  • To identify the on-going trends and anticipated growth in the next five years
  • To help industry consultants, blood plasma manufacturers, suppliers and distributors align their market-centric strategies
  • To gain insights on the prevalent market entry strategies in blood plasma market for domestic as well as foreign companies
  • To obtain research based business decision and add weight to presentations and marketing material
  • To gain competitive knowledge of leading players
  • To avail limited customization in the report without any extra charges and get research data or trends added in the report as per the buyer's specific needs

Table of Contents

1. Research Methodology

2. Product Overview

3. Executive Summary

4. Global Blood Plasma Market: An Analysis

  • 4.1. Global Blood Plasma Market: Size, Growth and Forecast
    • 4.1.1.By Value & Forecast
  • 4.2. Global Blood Plasma Market: Segment Shares & Analysis
    • 4.2.1.By Product Type
    • 4.2.2.By Company
  • 4.3. Global Albumin Type Blood Plasma Market: Size, Growth and Forecast
    • 4.3.1.By Volume
    • 4.3.2.By Value
    • 4.3.3. By Company
  • 4.4. Global IVIG Type Blood Plasma Market: Size, Growth and Forecast
    • 4.4.1. By Value
    • 4.4.2. By Volume
  • 4.5. Global Factor VIII Type Blood Plasma Market: Size, Growth and Forecast
    • 4.5.1. verview
    • 4.5.2. By Value
    • 4.5.3. By Volume
  • 4.6. Other Blood Products Market: Size, Growth and Forecast
    • 4.6.1.By Value (Forecast 2020F)

5. North America Blood Plasma Market: Size, Growth and Forecast

  • 5.1. Overview
  • 5.2. By Value (Forecast 2015E-2020F)
  • 5.3. Factors Affecting Market

6. APAC Blood Plasma Market: Size, Growth and Forecast

  • 6.1. Overview
  • 6.2. By Value (Forecast 2015E-2020F)
  • 6.3. Factors Affecting Market

7. Europe Blood Plasma Market: Size, Growth and Forecast

  • 7.1. By Value (Forecast 2015E-2020F)

8. RoW Blood Plasma Market: Size, Growth and Forecast

  • 8.1. Overview
  • 8.2. By Value (Forecast 2015E-2020F)
  • 8.3. Factors Affecting Market

9. Blood Plasma Market Trends

  • 9.1.Overview
    • 9.1.1.Solid and Stable Pricing Power in IG Market
    • 9.1.2.Fast Growth of SCIG Market
    • 9.1.3.Industrial Fractionators Planning Capacity Expansion
    • 9.1.4.Increase in Albumin Market in China
    • 9.1.5.Immunoglobulin Segment- High Profitability and Strength

10. Global Blood Plasma Market Dynamics

  • 10.1. Growth Drivers
    • 10.1.1. Augmentation in Plasma accumulations in the US
    • 10.1.2. Rise in Global Healthcare Expenditure
    • 10.1.3. Growth in Ageing Population
    • 10.1.4. Growth in Male Population
    • 10.1.5. Development Potential from New Indications
  • 10.2. Challenges
    • 10.2.1. Rivalry from Recombinant Factor VIII
    • 10.2.2. Prospective Threat to Immunoglobulin Market
    • 10.2.3. Costing Pressure in Tenders in Plasma-Derived FVIII Market
    • 10.2.4. High Manufacturing and Safety Cost

11. Blood Plasma Market: Policy and Regulatory Landscape

  • 11.1.WHO Blood Safety Regulations
  • 11.2.FDA Blood Safety Regulations
  • 11.3.CANADA CAN/CSA-Z902-10 (R2015) - Blood and blood components
  • 11.4.PHARMACEUTICAL AND FOOD SAFETY BUREAU (PFSB) JAPAN
  • 11.5.UK Blood Safety Regulations
  • 11.6.Australia Blood Safety Regulations
  • 11.7.India Plasma Product Safety Regulations

12. Blood Plasma Market: Value Chain Analysis

  • 12.1.Supply Chain Diagram
  • 12.2.BLOOD PLASMA SUPPLY CHAIN

13. Blood Plasma Trade Data Analysis

  • 13.1.Top 5 Nations with Import By Volume (Million KGS)
  • 13.2.Top 5 Nations with Export By Volume (Million KGS)
  • 13.3.Top 5 Nations with Import by Value (Billion $)
  • 13.4.Top 5 Nations with Export by Value (Billion $)

14. Blood Plasma Market: Porter's Five Force Analysis

  • 14.1.Porter Five Force Model Blood Plasma

15. Blood Plasma Market: Competitive landscape

  • 15.1.Blood Plasma Market: Company Financials
    • 15.1.1. Top 5 Companies Sales
    • 15.1.2. Bottom 5 Companies Sales
    • 15.1.3. Top 5 Companies EBITDA
    • 15.1.4. Bottom 5 Companies EBITDA
    • 15.1.5. Top 5 Companies EBIT
    • 15.1.6. Bottom 5 Companies EBIT
    • 15.1.7. Top 5 Companies PBT
    • 15.1.8. Bottom 5 Companies PBT
    • 15.1.9. Top 5 Companies PAT
    • 15.1.10. Bottom 5 Companies PAT
  • 15.2. Company Ratios
    • 15.2.1. Top 5 Companies Current Ratio
    • 15.2.2. Bottom 5 Companies Current Ratio
    • 15.2.3. Top 5 Companies Profit Margin
    • 15.2.4. Bottom 5 Companies Profit Margin
    • 15.2.5. Top 5 Companies Debt Equity Ratio

16. Global Blood Plasma Market: Company Profiles

  • 16.1.CSL Ltd.
  • 16.2Baxter International Inc
  • 16.3Grifols S.A
  • 16.4Antares Pharma Inc
  • 16.5Emergent BioSolutions, Inc.
  • 16.6AMAG Pharmaceuticals, Inc.
  • 16.7Cipla
  • 16.8Octopharma
  • 16.9Biota Pharmaceuticals, Inc.
  • 16.10BioDelivery Sciences International, Inc.

17. Strategic Recommendations

List of Figures:

  • Figure 1: Global Blood Plasma Market Size, By Value, 2010-2014 (USD Billion)
  • Figure 2: Growth in Global Ageing Population (2010-2014) in Million
  • Figure 3: Global Blood Plasma Market Size, By Value, 2015E-2020F (USD Billion)
  • Figure 4: Global Per Capita Health care Expenditure (USD)
  • Figure 5: Blood plasma Market Share, By Product 2014
  • Figure 6: Blood Plasma Market Share, By Product, By Value, 2014(USD Billion)
  • Figure 7: Blood plasma Market, By Company Share 2014 (Percentage)
  • Figure 8: Blood Plasma Market, Company Share, By Value, 2014(USD Billion)
  • Figure 9: Blood plasma Market Immunoglobulin By Company 2014
  • Figure 10: Blood plasma Market Factor VIII By Company 2014
  • Figure 11: Global Albumin Market Size, By Volume, 2010-2014 (tons)
  • Figure 12: Global Albumin Market Size, By Volume, 2015E-2020E (tons)
  • Figure 13: Global Albumin Market Size, By Value, 2010-2014 (USD Billion)
  • Figure 14: Global Albumin Market Size, By Value, 2015E-2020E (USD Billion)
  • Figure 15: Blood plasma Market Albumin By Company 2014
  • Figure 16: Global IVIG Market Size, By Volume, 2010-2014 (tons)
  • Figure 17: Global IVIG Market Size, By Volume, 2015E-2020E (tons)
  • Figure 18: Global IVIG Market Size, By Value, 2010-2014 (USD Billion)
  • Figure 19: Global IVIG Market Size, By Value, 2015E-2020E (USD Billion)
  • Figure 20: Global Factor VIII Market Size, By Value, 2010-2014 (USD Billion)
  • Figure 21: Global Factor VIII Market Size, By Value, 2015E-2020E (USD Billion)
  • Figure 22: Global Factor VIII Market Size, By Volume, 2010-2014 (International Units)
  • Figure 23: Global Factor VIII Market Size, By Volume, 2015E-2020E (International Units)
  • Figure 24: Other Blood Products Market Size, By Value, 2010-2014 (USD Billion)
  • Figure 25: Other Blood Products Market Size, By Value, 2015E-2020E (USD Billion)
  • Figure 26: North America Blood Plasma Market Size, By Value, 2010-2014 (USD Billion)
  • Figure 27: North America Blood Plasma Market Size, By Value, 2015E-2020E (USD Billion)
  • Figure 28: North America Aging Population, 2010-2020 (Million)
  • Figure 29: North America Blood Plasma Export to China, By Value, 2010-2014 (USD Billion)
  • Figure 30: Plasma Collection In America, By Volume, 2010-2014 (Million Litres)
  • Figure 31: APAC Blood Plasma Market Size, By Value, 2010-2014 (USD Billion)
  • Figure 32: APAC Blood Plasma Market Size, By Value, 2015E-2020E (USD Billion)
  • Figure 33: China Blood Plasma Import from North America, By Value, 2010-2014 (USD Million)
  • Figure 34: Europe Blood Plasma Market Size, By Value, 2010-2014 (USD Billion)
  • Figure 35: Europe Blood Plasma Market Size, By Value, 2015E-2020E (USD Billion)
  • Figure 36: ROW Blood Plasma Market Size, By Value, 2010-2014 (USD Billion)
  • Figure 37: ROW Blood Plasma Market Size, By Value, 2015E-2020E (USD Billion)
  • Figure 38: IVIG (KG/M) Usage Comparison
  • Figure 39: US Plasma Accumulations (2010-2014)
  • Figure 40: Rise in Global Healthcare Expenditure, 2010-2014 USD
  • Figure 41: Growth in Global Ageing Population (2010-2014) Million
  • Figure 42: Growth in Male Population, 2010-2014 (Million)
  • Figure 43: Blood Plasma Imports, By Top Countries, 2010-2014 (Million KGS)
  • Figure 44: Blood Plasma Exports, By Top Countries, 2010-2014 (Million KGS)
  • Figure 45: Blood Plasma Imports, By Top Countries, 2010-2014 (Billion $)
  • Figure 46: Blood Plasma Exports, By Top Countries, 2010-2014 (Billion $)
  • Figure 47: Top 5 Companies Sales in USD Billion
  • Figure 48: Bottom 5 Companies Sales in USD Million
  • Figure 49: Top 5 Companies EBITDA in USD Billion
  • Figure 50: Bottom 5 Companies EBITDA in USD Billion
  • Figure 51: Top 5 Companies EBIT in USD Billion
  • Figure 52: Bottom 5 Companies EBIT in USD Billion
  • Figure 53: Top 5 Companies PBT in USD Billion
  • Figure 54: Bottom 5 Companies PBT in USD Billion
  • Figure 55: Top 5 Companies PAT in USD Billion
  • Figure 56: Bottom 5 Companies PAT in USD Billion
  • Figure 57: Top 5 Companies Current Ratio
  • Figure 58: Bottom 5 Companies Current Ratio
  • Figure 59: Top 5 Companies Profit Margin
  • Figure 60: Bottom 5 Companies Profit Margin
  • Figure 61: Top 5 Companies Debt Equity Ratio
  • Figure 62: CSL Ltd. Percentage Revenue, By Product Segment (2014-2015)
  • Figure 63: CSL Ltd. Percentage Revenue, By Geography (2014-2015)
  • Figure 64: CSL Ltd. Sales (USD Billion) 2010-2014
  • Figure 65: Baxter International Inc. Percentage Revenue, By Product Segment (2014)
  • Figure 66: Baxter International Inc. Percentage Revenue, By Geography (2014)
  • Figure 67: Baxter International Inc. Sales (USD Billion) 2010-2014
  • Figure 68: Grifols S.A Percentage Revenue, By Product Segment (2014)
  • Figure 69: Grifols S.A Percentage Revenue, By Geography (2014)
  • Figure 70: Grifols SA Sales (USD Billion) 2010-2014
  • Figure 71: Antares Pharma Inc. Revenue (USD Billion) 2010-2014
  • Figure 72: Emergent BioSolutions, Inc. Revenue (USD Billion) 2010-2014
  • Figure 73: AMAG Pharmaceuticals, Inc. Revenue (USD Billion) 2010-2014
  • Figure 74: Octopharma Revenue (USD Billion) 2010-2014
  • Figure 75: Biota Pharmaceuticals, Inc. Revenue (USD Billion) 2010-2014
  • Figure 76: BioDelivery Sciences International, Inc. Revenue (USD Billion) 2010-2014
  • Figure 77: Flamel Technologies SA. Revenue (USD Billion) 2010-2014
Back to Top